May 9, 2018 — Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
April 10, 2018 — Researchers have developed a new imaging agent that could help guide and assess treatments for people ...
March 8, 2018 – Doctors contemplating the best therapy for lung cancer patients may soon be able to predict the efficacy ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear ...
February 21, 2018 — Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the ...
February 5, 2018 — Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark ...
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new radiotracer, 2 ...
December 28, 2017 — In the December featured basic science article in The Journal of Nuclear Medicine, Belgian ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
October 27, 2017 — The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a ...
October 25, 2017 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria ...
October 4, 2017 — Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development ...
September 18, 2017 — Toshiba Medical announced that it will display several new enhancements to its existing computed ...
September 14, 2017 — Researchers have demonstrated a new, effective way to precisely identify and localize prostate ...
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALCON ...
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for ...
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and ...
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document with ...
August 16, 2017 — In the featured translational article in the August issue of The Journal of Nuclear Medicine ...